乳房再造并发症风险:有无乳房切除术后放疗的个体化风险估计机器学习列线图
本研究分析了1997年至2017年间1617例接受乳房切除和乳房再造的乳腺癌患者,利用机器学习模型构建列线图预测有无乳房切除术后放疗情况下的再造并发症风险。中位随访6.6年,各模型内部验证的受试者工作特征曲线下面积分别为感染73%、包膜挛缩75%、绝对假体失败76%、总体假体失败68%。多变量分析显示,质子放疗相比无放疗显著增加包膜挛缩风险(OR 15.3,p<0.001),高于光子联合电子 boost 相比无放疗的风险(OR 2.5,p=0.01)。
要点
- 机器学习列线图可预测乳房再造并发症,内部验证AUC 68%-76%。
- 质子放疗相比无放疗显著增加包膜挛缩风险(OR 15.3,p<0.001)。
- 乳晕周围切口和假体完全肌肉覆盖分别是感染和包膜挛缩的重要预测因素。
核心结论
- 使用机器学习构建的列线图可预测有无放疗的乳房切除术后乳房再造并发症。
研究设计与样本
- 1997年至2017年间分析1617例接受乳房切除和乳房再造的乳腺癌患者。
- 纳入自体重建、组织扩张器/假体再造和单阶段直接假体再造。
- 放疗采用三维适形光子或质子治疗。
- 并发症终点基于再次手术记录定义为需清创的感染/坏死;假体患者定义为需包膜切开术的包膜挛缩和假体失败。
- 采用LASSO惩罚回归从10折交叉验证中选择预测误差最小的预测因子子集,构建列线图并进行内部交叉验证。
主要发现
- 中位随访6.6年。
- 1617例患者中,23%接受自体重建,39%接受直接假体再造,37%接受组织扩张器/假体再造。
- 759例接受乳房切除术后放疗的患者中,8.3%接受胸壁和淋巴结质子治疗,43%接受胸壁boost。
- 内部验证各模型受试者工作特征曲线下面积:感染73%,包膜挛缩75%,绝对假体失败76%,总体假体失败68%。
- 多变量分析:质子放疗相比无放疗显著增加包膜挛缩风险(OR 15.3,p<0.001),高于光子联合电子boost相比无放疗(OR 2.5,p=0.01)。
关键数值与推荐
- 乳晕周围切口和假体完全肌肉覆盖分别是感染和包膜挛缩的重要预测因素。
- 质子放疗相比无放疗的包膜挛缩OR为15.3(p<0.001)。
- 光子联合电子boost相比无放疗的包膜挛缩OR为2.5(p=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to create a nomogram using machine learning models predicting risk of breast reconstruction complications with or without postmastectomy radiation therapy. METHODS: Between 1997 and 2017, 1617 breast cancer patients undergoing mastectomy and breast reconstruction were analyzed. Those with autologous, tissue expander/implant, and single-stage direct-to-implant reconstruction were included. Postmastectomy radiation therapy was delivered either with three-dimensional conformal photon or proton therapy. Complication endpoints were defined based on surgical reintervention operative notes as infection/necrosis requiring débridement. For implant-based patients, complications were defined as capsular contracture requiring capsulotomy and implant failure. For each complication endpoint, least absolute shrinkage and selection operator-penalized regression was used to select the subset of predictors associated with the smallest prediction error from 10-fold cross-validation. Nomograms were built using the least absolute shrinkage and selection operator-selected predictors, and internal validation using cross-validation was performed. RESULTS: Median follow-up was 6.6 years. Among 1617 patients, 23 percent underwent autologous reconstruction, 39 percent underwent direct-to-implant reconstruction, and 37 percent underwent tissue expander/implant reconstruction. Among 759 patients who received postmastectomy radiation therapy, 8.3 percent received proton-therapy to the chest wall and nodes and 43 percent received chest wall boost. Internal validation for each model showed an area under the receiver operating characteristic curve of 73 percent for infection, 75 percent for capsular contracture, 76 percent for absolute implant failure, and 68 percent for overall implant failure. Periareolar incisions and complete implant muscle coverage were found to be important predictors for infection and capsular contracture, respectively. In a multivariable analysis, we found that protons compared to no postmastectomy radiation therapy significantly increased capsular contracture risk (OR, 15.3; p < 0.001). This was higher than the effect of photons with electron boost versus no postmastectomy radiation therapy (OR, 2.5; p = 0.01). CONCLUSION: Using machine learning, these nomograms provided prediction of postmastectomy breast reconstruction complications with and without radiation therapy. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Naoum GE, Ho AY, Shui A, et al. Risk of Developing Breast Reconstruction Complications: A Machine-Learning Nomogram for Individualized Risk Estimation with and without Postmastectomy Radiation Therapy. Plast Reconstr Surg. 2022. PMID: 34758003. doi:10.1097/PRS.0000000000008635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。